Cargando…
MitraClip for the treatment of heart failure with mitral regurgitation: A cost-effectiveness analysis in a Chinese setting
BACKGROUND: Heart failure (HF) with mitral regurgitation is associated with decreased survival. Guideline-directed medical therapy and transcatheter edge-to-edge repair (TEER) are the main options for HF patients with severe mitral regurgitation who are considered high-risk or prohibitive. To date,...
Autores principales: | Xia, Wengang, Han, Kangning, Lou, Yake |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691652/ https://www.ncbi.nlm.nih.gov/pubmed/36440042 http://dx.doi.org/10.3389/fcvm.2022.970118 |
Ejemplares similares
-
Selection of the Optimal Candidate to MitraClip for Secondary Mitral Regurgitation: Beyond Mitral Valve Morphology
por: Salvatore, Tanya, et al.
Publicado: (2021) -
Cost-effectiveness of the MitraClip device in German heart failure patients with secondary mitral regurgitation
por: Estler, Bent, et al.
Publicado: (2022) -
Percutaneous treatment of mitral regurgitation with MitraClip device
por: Pregowski, Jerzy, et al.
Publicado: (2013) -
Managing mitral regurgitation: focus on the MitraClip device
por: Magruder, J Trent, et al.
Publicado: (2016) -
Considerations on the use of MitraClip in the treatment of mitral regurgitation
por: Musumeci, Giuseppe, et al.
Publicado: (2020)